Heparin Sodium Injection: Out of Specification
Dernière mise à jour
Summary
Produit
HEPARIN SODIUM INJ IN 5% DEX 100UNITS/ML
Problème
Health products - Product quality
Ce qu’il faut faire
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
HEPARIN SODIUM INJ IN 5% DEX 100UNITS/ML |
HEPARIN SODIUM INJ IN 5% DEX 100UNITS/ML |
DIN 02209721 |
Solution |
Heparin Sodium 10,000 UNITS/100 ML, |
J2A262 |
Problème
Potential low Anti-Factor Ila potency out of specification.
Ce que vous devriez faire
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Contexte
Depth of recall: Wholesalers, Retailers, End Users
Details
Original published date: 2023-03-01
Type d’avis ou de rappel
Health product recall
Catégorie
Health product - Drugs
Entreprises
B. Braun Medical Inc.
2525 McGaw Ave, Irvine CA, United States
Published by
Health Canada
Audience
General public
Healthcare
Industry
Classe de rappel
Type II
Identification number
RA-73062